Abstract
In the last decade, from the early large-scale multigene profiling using traditional Sanger sequencing to the more recent next-generation whole-exome and whole-genome sequencing, the genomic landscapes of renal cell carcinoma (RCC), consisting mainly of clear-cell, papillary (1 and 2), and chromophobe subtypes, have been characterized. This genomic information, coupled with DNA methylation, has shed light on the molecular biology of RCC and created tremendous opportunities for future research that hopefully will lead to improvement in diagnosis, prognosis, treatment, and prevention of RCC. This chapter will summarize the most recent genomic and DNA methylation profiles of these three subtypes of RCC and highlight the major biological pathways involved and their clinical relevance.
| Original language | English |
|---|---|
| Title of host publication | Renal Cell Carcinoma |
| Subtitle of host publication | Molecular Features and Treatment Updates |
| Publisher | Springer Japan |
| Pages | 83-103 |
| Number of pages | 21 |
| ISBN (Electronic) | 9784431555315 |
| ISBN (Print) | 9784431555308 |
| DOIs | |
| State | Published - 01 01 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© Springer Japan KK 2017. All rights are reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Genomics
- RCC
Fingerprint
Dive into the research topics of 'Molecular genetics of renal cell carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver